HAVCR2 and acute myeloid leukemia: Moreover, TCGA data of 157 non-M3 AML patients were subsequently analyzed and showed that TIM-3 expression was not associated with the OS of patients, either in the whole cohort or in any ELN risk group, consistent with results of our cohort.